How to appeal a Blue Cross Blue Shield of Michigan ibs & functional gi denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Blue Cross Blue Shield of Michigan-specific note: Largest insurer in Michigan (~4.5M members). Statutory non-profit mutual. Switched PBM from Express Scripts to OptumRx effective January 2024 — appeals around 2024-2025 may involve formulary disruption. Michigan DIFS oversight.

What Blue Cross Blue Shield of Michigan's policy requires for ibs & functional gi

Cited policy: BCBS Gastroparesis Gimoti / Domperidone EAP Coverage

Confirmed gastroparesis by 4-hour gastric scintigraphy (>10% retention at 4h, EggBeater protocol). Rome IV symptoms. Mechanical obstruction ruled out by EGD. HbA1c if diabetic. Trial / intolerance to oral metoclopramide.

How Blue Cross Blue Shield of Michigan denies ibs & functional gi — and how to counter it

Where Blue Cross Blue Shield of Michigan pushes back: 1) Gimoti experimental; 2) Domperidone not FDA-approved; 3) Try oral metoclopramide first.

Counter-arguments that hold up: Gimoti FDA-approved Jun 19, 2020 for diabetic gastroparesis adults — NOT experimental. Appropriate when oral absorption is impaired by gastroparesis itself. Domperidone available via FDA Expanded Access IND 21 CFR 312.305 for refractory cases. ACG 2022 Gastroparesis Guideline Camilleri Am J Gastroenterol 2022 conditional recommendation when metoclopramide failed/contraindicated due to TD risk. Submit 4h scintigraphy + oral metoclopramide trial outcome.

What Blue Cross Blue Shield of Michigan typically denies for ibs & functional gi

Across Blue Cross Blue Shield of Michigan's commercial and Medicare books, denials cluster around a small number of patterns. For ibs & functional gi, expect:

• Step therapy via OptumRx (PBM since 2024)
• Site-of-care reductions for infusions
• Behavioral health prior auth
• OON balance bill disputes

Treatments most often denied in this category

These are the ibs & functional gi treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Linzess
• Trulance
• Amitiza
• Motegrity
• Viberzi
• Xifaxan IBS-D

How to submit the appeal to Blue Cross Blue Shield of Michigan

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Blue Cross Blue Shield of Michigan cited in the denial.
3. File the appeal through Blue Cross Blue Shield of Michigan's portal (members: https://www.bcbsm.com ; providers: https://providers.bcbsm.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MI, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Blue Cross Blue Shield of Michigan's prior-authorization criteria by drug: Blue Cross Blue Shield of Michigan PA criteria on ApprovalHelp.